Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Western blotting analysis as a tool to study receptor tyrosine kinases.

Germano S, O'Driscoll L.

Methods Mol Biol. 2011;784:109-21. doi: 10.1007/978-1-61779-289-2_8.

PMID:
21898216
[PubMed - indexed for MEDLINE]
2.

Receptor tyrosine kinases as target for anti-cancer therapy.

Brunelleschi S, Penengo L, Santoro MM, Gaudino G.

Curr Pharm Des. 2002;8(22):1959-72. Review.

PMID:
12171522
[PubMed - indexed for MEDLINE]
3.

Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases.

Abella JV, Park M.

Am J Physiol Endocrinol Metab. 2009 May;296(5):E973-84. doi: 10.1152/ajpendo.90857.2008. Epub 2009 Feb 24. Review.

PMID:
19240253
[PubMed - indexed for MEDLINE]
Free Article
4.

Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.

Yu L, Saile K, Swartz CD, He H, Zheng X, Kissling GE, Di X, Lucas S, Robboy SJ, Dixon D.

Mol Med. 2008 May-Jun;14(5-6):264-75. doi: 10.2119/2007-00101.Yu. Erratum in: Mol Med. 2008 Jul-Aug;14(7-8):538.

PMID:
18231572
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases.

Peschard P, Park M.

Cancer Cell. 2003 Jun;3(6):519-23.

PMID:
12842080
[PubMed - indexed for MEDLINE]
Free Article
6.

Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.

Yip-Schneider MT, Lin A, Marshall MS.

Biochem Biophys Res Commun. 2001 Feb 2;280(4):992-7.

PMID:
11162624
[PubMed - indexed for MEDLINE]
7.

The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.

Pillay V, Allaf L, Wilding AL, Donoghue JF, Court NW, Greenall SA, Scott AM, Johns TG.

Neoplasia. 2009 May;11(5):448-58, 2 p following 458.

PMID:
19412429
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.

Camp ER, Yang A, Gray MJ, Fan F, Hamilton SR, Evans DB, Hooper AT, Pereira DS, Hicklin DJ, Ellis LM.

Cancer. 2007 Mar 15;109(6):1030-9.

PMID:
17311308
[PubMed - indexed for MEDLINE]
Free Article
9.

c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth.

Kiehne K, Herzig KH, Fölsch UR.

Pancreas. 1997 Jul;15(1):35-40.

PMID:
9211490
[PubMed - indexed for MEDLINE]
10.

Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1.

Gensler M, Buschbeck M, Ullrich A.

J Biol Chem. 2004 Mar 26;279(13):12110-6. Epub 2003 Dec 2.

PMID:
14660651
[PubMed - indexed for MEDLINE]
Free Article
11.

Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.

Matsumura I, Mizuki M, Kanakura Y.

Cancer Sci. 2008 Mar;99(3):479-85. doi: 10.1111/j.1349-7006.2007.00717.x. Epub 2008 Jan 2. Review.

PMID:
18177485
[PubMed - indexed for MEDLINE]
12.

Uncoupling ligand-dependent and -independent mechanisms for mitogen-activated protein kinase activation by the murine Ron receptor tyrosine kinase.

Wei X, Ni S, Correll PH.

J Biol Chem. 2005 Oct 21;280(42):35098-107. Epub 2005 Aug 15.

PMID:
16103119
[PubMed - indexed for MEDLINE]
Free Article
13.

Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.

Zisman-Rozen S, Fink D, Ben-Izhak O, Fuchs Y, Brodski A, Kraus MH, Bejar J, Ron D.

Oncogene. 2007 Sep 6;26(41):6093-8. Epub 2007 Apr 9.

PMID:
17420726
[PubMed - indexed for MEDLINE]
14.
15.

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.

Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM.

Cancer. 2005 Jul 15;104(2):427-38.

PMID:
15952180
[PubMed - indexed for MEDLINE]
Free Article
16.

Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.

Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E, Wang B.

Nat Cell Biol. 2001 May;3(5):527-30.

PMID:
11331884
[PubMed - indexed for MEDLINE]
17.

Autoinhibitory mechanisms in receptor tyrosine kinases.

Hubbard SR.

Front Biosci. 2002 Feb 1;7:d330-40. Review.

PMID:
11815286
[PubMed - indexed for MEDLINE]
18.
19.

Integrins regulate the linkage between upstream and downstream events in G protein-coupled receptor signaling to mitogen-activated protein kinase.

Short SM, Boyer JL, Juliano RL.

J Biol Chem. 2000 Apr 28;275(17):12970-7.

PMID:
10777598
[PubMed - indexed for MEDLINE]
Free Article
20.

p90 Ribosomal S6 kinase 2, a novel GPCR kinase, is required for growth factor-mediated attenuation of GPCR signaling.

Strachan RT, Allen JA, Sheffler DJ, Roth BL.

Biochemistry. 2010 Mar 30;49(12):2657-71. doi: 10.1021/bi901921k.

PMID:
20136148
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk